多发性骨髓瘤中的血管生成:在这一领域的25年研究
1Department of Translational Biomedicine and Neuroscience, University of Bari, Bari, Italy.
European journal of haematology
|September 8, 2025
概括
多发性骨髓瘤 (MM) 显示骨髓微血管密度增加,表明血管生成在其进展中起着关键作用. 抗血管生成药物为MM提供了一个有希望的,尽管有争议的治疗策略.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 血管生物学 血管生物学
背景情况:
- 骨髓的微血管密度在多发性骨髓瘤 (MM) 中显著增加,与未确定重要性 (MGUS) 的单克隆性骨髓瘤相比.
- 在MM的活性形式与非活性形式之间也注意到了这种增加.
研究的目的:
- 审查和总结有关血管新生在MM进展中的作用的关键文献发现.
- 探索抗血管性药物在治疗MM中的潜力.
主要方法:
- 关于1994年以来发表的研究的文献综述.
- 关于血管新生及其在多发性骨髓瘤中的影响的综合数据.
主要成果:
- 血管新生是多发性骨髓瘤进展的关键因素.
- 有证据表明,在MM中,微血管密度和疾病活性之间存在联系.
结论:
- 尽管有持续的辩论和不清楚的疗效,但血管生成抑制仍然是MM的有吸引力的治疗策略.
- 由于血管新生在MM进展中的关键作用,对新型抗血管原剂的进一步研究是有必要的.
相关概念视频
Mechanism of Angiogenesis
6.7K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.7K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K


